Rambam Health Care Campus

Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R (2024) Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, et al. Journal article BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations (2024) Peron A, D’Arco F, Aldinger KA, Smith-Hicks C, Zweier C, Gradek GA, Bradbury K, et al. Journal article Erratum to: Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: A study from the EUSTAR cohort(Rheumatology 2021DOI: 10.1093/rheumatology/keab510) (2022) Hughes M, Heal C, Henes J, Balbir-Gurman A, Distler J, Airo P, Mueller-Ladner U, et al. Journal article, Erratum PREDICTING OUTCOMES IN SYSTEMIC SCLEROSIS: STRATIFICATION BY AUTO-ANTIBODIES OUTPERFORMS CUTANEOUS SUBSETTING IN THE EUSTAR COHORT (2022) Elhai M, Boubaya M, Sritharan N, Balbir-Gurman A, Siegert E, Hachulla E, De Vries-Bouwstra J, et al. Conference contribution PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation (2021) Gulluni F, Prever L, Li H, Krafcikova P, Corrado I, Lo WT, Margaria JP, et al. Journal article Primary high-grade myoepithelial carcinoma of the lung: A study of three cases illustrating frequent SMARCB1-deficiency and review of the literature (2021) Agaimy A, Naroditsky I, Ben-Izhak O Journal article Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort (2021) Hughes M, Heal C, Henes J, Balbir-Gurman A, Distler J, Airo P, Mueller-Ladner U, et al. Journal article Pediatric Mesothelioma Tumors: The European Expert Group Contribution (2020) Orbach D, Andre N, Brecht I, Lopez Almaraz R, Ben Ami T, Wermersch S, Carton M, et al. Conference contribution Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article